Zobrazeno 1 - 10 of 481 pro vyhledávání: '"Jm, Coindre"'
2
Excellente réponse à la radiothérapie externe d’un synovialosarcome primitif de la glande parotide
Autor: A Asabbane, I Lalya, T Kebdani, K Hassouni, JM Coindre, BK El- Gueddari, N Benjaafar
Publikováno v: The Pan African Medical Journal, Vol 8, Iss 34 (2011)
Pan African Medical Journal; Vol 8, No 1 (2011)
Le synovialosarcome de la parotide est rare, peu de cas ont été rapportés dans la littérature. Nous rapportons l’observation d’une patiente âgée de 40 ans qui a présenté d’un synovialosarcome primitif de la parotide, dont le traitement
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2af0e1441a589c0bc784a6399174977
https://doi.org/10.4314/pamj.v8i1.71149
Zobrazit plný text záznamu
3
[Granular cell tumors of the skin of nonneural origin: report of 8 cases]
Autor: Lacroix-Triki M, Philippe Rochaix, Marques B, Jm, Coindre, Jj, Voigt
Publikováno v: Europe PubMed Central
We report six cases of benign fibrous histiocytoma, one case of dermatomyofibroma, one case of cutaneous leiomyosarcoma with a granular cell component. Besides the clinical, histologic and immunohistochemical features of the primary lesion, these tum
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::f95aa205dde94210cef86791e9930024
https://pubmed.ncbi.nlm.nih.gov/10349472
Zobrazit plný text záznamu
4
Prognostic variables for the selection of patients with operable soft tissue sarcomas to be considered in adjuvant chemotherapy trials
Autor: A Ravaud, NB Bui, JM Coindre, P Lagarde, P Tramond, F Bonichon, E Stöckle, G Kantor, M Trojani, J Chauvergne, D Marée
Publikováno v: British Journal of Cancer
From 1975 to 1988, 144 patients naive of treatment, with non-metastatic soft tissue sarcoma were treated at Fondation Bergonie by surgery, followed by radiotherapy and without chemotherapy. An analysis of prognostic variables was done on this populat
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87591006081cf55310f7eb936e66d510
https://pubmed.ncbi.nlm.nih.gov/1419644
Zobrazit plný text záznamu
6
[Neoadjuvant chemotherapy and combined conservative treatment of soft tissue sarcoma in the adult]
Autor: Cany L, Nb, Bui, Stöckle E, Jm, Coindre, Kantor G, Alain Ravaud
Publikováno v: Europe PubMed Central
Between 1980 and 1990, 64 adults with a locally advanced soft tissue sarcoma, but without metastasis, were treated with neoadjuvant chemotherapy before conservative local treatment. Tumour localizations were limbs in 26 patients (40.6%) and other par
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::de24aab1e79837c61497c6a4f9ad76b1
http://europepmc.org/abstract/med/1302534
Zobrazit plný text záznamu
7
Malignant cells have increased levels of common glycoprotein ligands of the endogenous cerebellar soluble lectin CSL
Autor: Maschke S, Robert J, Jm, Coindre, Kuchler S, Vincendon G, Jp, Zanetta
Publikováno v: Europe PubMed Central
The glycoprotein composition of various transformed cells or malignant tumors was analyzed and compared to their respective non-malignant control cells or tissues of several species, including man, using an endogenous carbohydrate-binding protein, th
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::e49520090efb7ed8d773c88744e5c042
http://europepmc.org/abstract/med/8269974
Zobrazit plný text záznamu
8
Akademický článek
Predictive value of tumor microenvironment on pathologic response to neoadjuvant chemotherapy in patients with undifferentiated pleomorphic sarcomas.
Autor: Guegan JP; Explicyte, Bordeaux, France., El Ghazzi N; Department of Medicine, Early Phase Trials and Sarcoma Units, Institut Bergonié, 229 Cours de l'Argonne, Bordeaux, France.; Unversity Hospital Center, Clermont Ferrand, France., Vibert J; DITEP, Gustave Roussy, Villejuif, France., Rey C; Explicyte, Bordeaux, France., Vanhersecke L; Department of Pathology, Institut Bergonié, Bordeaux, France., Coindre JM; Department of Pathology, Institut Bergonié, Bordeaux, France., Toulmonde M; Department of Medicine, Early Phase Trials and Sarcoma Units, Institut Bergonié, 229 Cours de l'Argonne, Bordeaux, France., Spalato Ceruso M; Department of Medicine, Early Phase Trials and Sarcoma Units, Institut Bergonié, 229 Cours de l'Argonne, Bordeaux, France., Peyraud F; Department of Medicine, Early Phase Trials and Sarcoma Units, Institut Bergonié, 229 Cours de l'Argonne, Bordeaux, France., Bessede A; Explicyte, Bordeaux, France., Italiano A; Department of Medicine, Early Phase Trials and Sarcoma Units, Institut Bergonié, 229 Cours de l'Argonne, Bordeaux, France. a.italiano@bordeaux.unicancer.fr.; Faculty of Medicine, University of Bordeaux, Bordeaux, France. a.italiano@bordeaux.unicancer.fr.
Publikováno v: Journal of hematology & oncology [J Hematol Oncol] 2024 Oct 23; Vol. 17 (1), pp. 100. Date of Electronic Publication: 2024 Oct 23.
Zobrazit plný text záznamu
9
Akademický článek
Spatial distribution of tumour immune infiltrate predicts outcomes of patients with high-risk soft tissue sarcomas after neoadjuvant chemotherapy.
Autor: Pasquali S; Molecular Pharmacology, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy. Electronic address: sandro.pasquali@istitutotumori.mi.it., Vallacchi V; Translational Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy., Lalli L; Translational Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy. Electronic address: luca.lalli@istitutotumori.mi.it., Collini P; Soft Tissue Tumor Pathology Unit, Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy., Barisella M; Pathology Unit, ASST Fatebenefratelli Sacco, Milan, Italy., Romagosa C; Pathology Department, Vall d'Hebron University Hospital, Barcelona, Spain., Bague S; Pathology Department, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain., Coindre JM; Department of Pathology, Institut Bergonié, 33000, Bordeaux, France; INSERM U1218 ACTION, Institut Bergonié, 33000, Bordeaux, France., Dei Tos AP; Surgical Pathology & Cytopathology Unit, Department of Medicine - DIMED, University of Padua, Padua, Italy., Palmerini E; Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies Unit IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy., Quagliuolo V; Surgery Department, IRCCS Humanitas Research Hospital, Rozzano, Italy., Martin-Broto J; Oncology Department, Fundación Jiménez Díaz University Hospital, Madrid, Spain., Lopez-Pousa A; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Carrer de Sant Quintí, 89, 08041, Barcelona, Spain., Grignani G; Medical Oncology Unit, Città della Salute e della Scienza Hospital, Turin, Italy., Blay JY; Centre Léon Bérard & Université Claude Bernard Lyon 1, Lyon, France., Beveridge RD; Department of Cancer Medicine, Hospital Universitari i Politècnic La Fe, Valencia, Spain., Casiraghi E; AnacletoLab, Department of Computer Science 'Giovanni degli Antoni', Università degli Studi di Milano, Milan, Italy., Brich S; Soft Tissue Tumor Pathology Unit, Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy., Renne SL; Pathology Department, IRCCS Humanitas Research Hospital, Rozzano, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy., Bergamaschi L; Translational Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy., Vergani B; School of Medicine and Surgery, University of Milano Bicocca, Monza, Italy., Sbaraglia M; Surgical Pathology & Cytopathology Unit, Department of Medicine - DIMED, University of Padua, Padua, Italy., Casali PG; Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy., Rivoltini L; Translational Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy. Electronic address: licia.rivoltini@istitutotumori.mi.it., Stacchiotti S; Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy., Gronchi A; Sarcoma Service, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy. Electronic address: alessandro.gronchi@istitutotumori.mi.it.
Publikováno v: EBioMedicine [EBioMedicine] 2024 Aug; Vol. 106, pp. 105220. Date of Electronic Publication: 2024 Jul 16.
Zobrazit plný text záznamu
10
Akademický článek
Integration of pre-treatment computational radiomics, deep radiomics, and transcriptomics enhances soft-tissue sarcoma patient prognosis.
Autor: Crombé A; Department of Oncologic Imaging, Bergonié Institute, F-33076, Bordeaux, France. amandine.crombe@chu-bordeaux.fr.; Department of Radiology, Pellegrin University Hospital, F-33076, Bordeaux, France. amandine.crombe@chu-bordeaux.fr.; Bordeaux Institute of Oncology, BRIC U1312, Sarcotarget team, INSERM, University of Bordeaux, Institut Bergonié, F-33000, Bordeaux, France. amandine.crombe@chu-bordeaux.fr., Lucchesi C; Department of Bioinformatics, Bergonié Institute, F-33076, Bordeaux, France., Bertolo F; Department of Bioinformatics, Bergonié Institute, F-33076, Bordeaux, France., Kind M; Department of Oncologic Imaging, Bergonié Institute, F-33076, Bordeaux, France., Spalato-Ceruso M; Bordeaux Institute of Oncology, BRIC U1312, Sarcotarget team, INSERM, University of Bordeaux, Institut Bergonié, F-33000, Bordeaux, France.; Department of Medical Oncology, Bergonié Institute, F-33076, Bordeaux, France., Toulmonde M; Bordeaux Institute of Oncology, BRIC U1312, Sarcotarget team, INSERM, University of Bordeaux, Institut Bergonié, F-33000, Bordeaux, France.; Department of Medical Oncology, Bergonié Institute, F-33076, Bordeaux, France., Chaire V; Bordeaux Institute of Oncology, BRIC U1312, Sarcotarget team, INSERM, University of Bordeaux, Institut Bergonié, F-33000, Bordeaux, France.; Department of Pathology, Bergonié Institute, F-33076, Bordeaux, France., Michot A; Bordeaux Institute of Oncology, BRIC U1312, Sarcotarget team, INSERM, University of Bordeaux, Institut Bergonié, F-33000, Bordeaux, France.; Department of Oncologic Surgery, Bergonié Institute, F-33076, Bordeaux, France., Coindre JM; Bordeaux Institute of Oncology, BRIC U1312, Sarcotarget team, INSERM, University of Bordeaux, Institut Bergonié, F-33000, Bordeaux, France.; Department of Pathology, Bergonié Institute, F-33076, Bordeaux, France., Perret R; Department of Pathology, Bergonié Institute, F-33076, Bordeaux, France., Le Loarer F; Bordeaux Institute of Oncology, BRIC U1312, Sarcotarget team, INSERM, University of Bordeaux, Institut Bergonié, F-33000, Bordeaux, France.; Department of Pathology, Bergonié Institute, F-33076, Bordeaux, France., Bourdon A; Department of Bioinformatics, Bergonié Institute, F-33076, Bordeaux, France., Italiano A; Bordeaux Institute of Oncology, BRIC U1312, Sarcotarget team, INSERM, University of Bordeaux, Institut Bergonié, F-33000, Bordeaux, France.; Department of Medical Oncology, Bergonié Institute, F-33076, Bordeaux, France.
Publikováno v: NPJ precision oncology [NPJ Precis Oncol] 2024 Jun 07; Vol. 8 (1), pp. 129. Date of Electronic Publication: 2024 Jun 07.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje